- List
- By Topic
- On Map
- Search Details

Bromocriptine OR (+)-Bromocriptine OR BROMOCRIPTINE MESYLATE OR CB-154 OR CB-154 MESYLATE OR BROMOCRIPTINE MESILATE OR PARLODEL OR CYCLOSET OR BROMOCRIPTINE
Need help? See RSS Feeds
Choose a feed type:

Bromocriptine OR (+)-Bromocriptine OR BROMOCRIPTINE MESYLATE OR CB-154 OR CB-154 MESYLATE OR BROMOCRIPTINE MESILATE OR PARLODEL OR CYCLOSET OR BROMOCRIPTINE (38 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03575000 | Not yet recruiting | Bromocriptine for Patients With Schizophrenia and Impaired Glucose Tolerance |
|
|
Interventional |
Phase 4 |
|
U.S. Fed / Other |
|
|
20 | All | 18 Years and older (Adult, Older Adult) | NCT03575000 | PRO0002368 | July 1, 2018 | May 31, 2019 | December 1, 2019 | July 2, 2018 | July 2, 2018 | ||||
2 | NCT03496545 | Recruiting | Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
40 | All | 18 Years to 100 Years (Adult, Older Adult) | NCT03496545 | 18-24766 | BFF | November 30, 2018 | July 1, 2019 | July 1, 2019 | April 12, 2018 | December 4, 2018 |
|
||
3 | NCT03525002 | Recruiting | Dopamine Action on Metabolism in Relation to Genotype |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
150 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT03525002 | DopamineGenetics01 | May 3, 2018 | May 2021 | December 2021 | May 15, 2018 | July 3, 2018 |
|
|||
4 | NCT03384524 | Not yet recruiting | Evaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DME |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
120 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03384524 | The BEAT DME Study | March 2018 | May 2019 | May 2019 | December 27, 2017 | December 27, 2017 | ||||
5 | NCT02929485 | Unknown † | Dopaminergic Modulation of Frontostriatal Function With a Dopamine Agonist and COMT Inhibitor |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
38 | All | 18 Years to 50 Years (Adult) | NCT02929485 | 2011-11-3748 | July 2013 | January 2018 | January 2018 | October 11, 2016 | October 11, 2016 |
|
|||
6 | NCT02846493 | Unknown † | Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
200 | Female | 20 Years to 40 Years (Adult) | NCT02846493 | SYSU-ohss-001 | August 2016 | June 2018 | June 2018 | July 27, 2016 | July 27, 2016 |
|
|||
7 | NCT02682901 | Completed | Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes Subjects |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
84 | All | 30 Years to 80 Years (Adult, Older Adult) | NCT02682901 | 15-06-FB-0119 | June 2015 | December 2018 | December 2018 | February 17, 2016 | February 11, 2019 |
|
|||
8 | NCT02590601 | Recruiting | Bromocriptine in the Treatment of Peripartum Cardiomyopathy |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
80 | Female | 18 Years and older (Adult, Older Adult) | NCT02590601 | MP-33-2015-1874 (MP) | BRO-HF | January 1, 2017 | January 1, 2023 | January 1, 2023 | October 29, 2015 | September 6, 2017 |
|
||
9 | NCT02544321 | Recruiting | Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 Diabetes |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
133 | All | 12 Years to 60 Years (Child, Adult) | NCT02544321 | 15-1309 UL1TR001082 |
September 2015 | December 2018 | December 2018 | September 9, 2015 | June 20, 2018 |
|
|||
10 | NCT02428946 | Completed | Bromocriptine and Insulin Sensitivity |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
15 | Male | 18 Years to 30 Years (Adult) | NCT02428946 | NL49417.018.14 METC 2014/147 | BIS | October 2014 | November 2015 | December 2015 | April 29, 2015 | May 24, 2016 |
|
||
11 | NCT02428933 | Completed | Dopaminergic Effects on Brown Adipose Tissue |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
8 | Male | 18 Years to 30 Years (Adult) | NCT02428933 | METC nr 2013_107 | DEBAT | October 2013 | February 2014 | February 2014 | April 29, 2015 | April 29, 2015 |
|
||
12 | NCT02299050 | Completed | Effect of Cycloset on Glycemic Control When Added to GLP-1 Analogue Therapy |
|
|
Interventional |
Phase 4 |
|
Other / Industry |
|
|
20 | All | 30 Years to 69 Years (Adult, Older Adult) | NCT02299050 | HSC20130330H | June 2014 | April 30, 2018 | April 30, 2018 | November 24, 2014 | May 28, 2018 |
|
|||
13 | NCT02265484 | Completed | To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
50 | All | 18 Years and older (Adult, Older Adult) | NCT02265484 | ILBS-bromocriptine-01 | November 2013 | January 2015 | January 2015 | October 16, 2014 | November 22, 2016 |
|
|||
14 | NCT02233023 | Completed | Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
705 | All | Child, Adult, Older Adult | NCT02233023 | 248.342 | June 1998 | June 2000 | September 8, 2014 | September 8, 2014 | |||||
15 | NCT02172573 | Completed | Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
315 | All | 20 Years and older (Adult, Older Adult) | NCT02172573 | 248.505 | April 1999 | July 2000 | June 24, 2014 | June 24, 2014 | |||||
16 | NCT02133755 | Unknown † | Effect of Bromocriptine on Insulin Resistance in Polycystic Ovarian Syndrome - A Pilot Study |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
60 | Female | 18 Years to 45 Years (Adult) | NCT02133755 | PCOS-Pilot | PCOS-Pilot | July 2014 | July 2015 | December 2015 | May 8, 2014 | May 8, 2014 |
|
||
17 | NCT02078440 | Completed | Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
18 | All | 10 Years to 17 Years (Child) | NCT02078440 | VS-PEDS BA-2010 | January 2014 | June 2016 | June 2016 | March 5, 2014 | August 29, 2016 |
|
|||
18 | NCT01893450 | Terminated | Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune Treatment |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
31 | All | 18 Years to 45 Years (Adult) | NCT01893450 | DIA19508091 | June 2008 | June 2013 | June 2013 | July 9, 2013 | July 9, 2013 |
|
|||
19 | NCT01821001 | Completed | Vaginal Bromocriptine for Treatment of Adenomyosis |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
1 | Female | 25 Years to 55 Years (Adult) | NCT01821001 | 11-007353 | March 2013 | September 2017 | January 2018 | March 29, 2013 | January 12, 2018 |
|
|||
20 | NCT01673724 | Completed | Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
121 | All | 30 Years and older (Adult, Older Adult) | NCT01673724 | SKL001 | February 2012 | May 23, 2016 | May 23, 2016 | August 28, 2012 | September 15, 2017 |
|
|||
21 | NCT01474018 | Completed | QR-Bromocriptine as an Adjunct to Insulin and Metformin in the Treatment of Type 2 Diabetes |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
15 | All | 30 Years to 65 Years (Adult, Older Adult) | NCT01474018 | QR-Bromo | November 2011 | May 2012 | June 2012 | November 17, 2011 | May 22, 2014 |
|
|||
22 | NCT00998556 | Completed | Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum Cardiomyopathy |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
64 | Female | 18 Years and older (Adult, Older Adult) | NCT00998556 | PPCM | PPCM | June 2010 | March 2016 | August 2016 | October 20, 2009 | November 18, 2016 |
|
||
23 | NCT00990353 | Recruiting | A Model to Identify Specific Predictors of Spatial Neglect Recovery |
|
Observational |
|
Other / NIH |
|
|
80 | All | 18 Years and older (Adult, Older Adult) | NCT00990353 | D-624-08 1R01NS055808 |
January 2009 | January 2019 | October 2020 | October 6, 2009 | August 8, 2018 |
|
|||||
24 | NCT00650520 | Completed | Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate Tablets |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
119 | All | 18 Years to 45 Years (Adult) | NCT00650520 | BROM-0734 | May 2007 | July 2007 | July 2007 | April 1, 2008 | April 1, 2008 |
|
|||
25 | NCT00649168 | Completed | Fed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mg |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
120 | All | 18 Years to 45 Years (Adult) | NCT00649168 | BROM-0733 | April 2007 | June 2007 | June 2007 | April 1, 2008 | April 1, 2008 |
|
|||
26 | NCT00451672 | Unknown † | The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
25 | All | 20 Years to 60 Years (Adult) | NCT00451672 | 950912 | January 2007 | December 2007 | March 23, 2007 | March 23, 2007 |
|
||||
27 | NCT00441363 | Terminated Has Results |
Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
66 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT00441363 | 165-AD-04-03-US-2 | February 2005 | February 2006 | March 2006 | February 28, 2007 | May 9, 2016 | May 9, 2016 | |||
28 | NCT00377676 | Completed Has Results |
Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
3095 | All | 30 Years to 80 Years (Adult, Older Adult) | NCT00377676 | 165-AD-04-03-US-1 | July 2004 | January 2007 | January 2007 | September 18, 2006 | June 10, 2016 | October 28, 2011 | |||
29 | NCT00315081 | Unknown † | Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
20 | Male | 18 Years to 60 Years (Adult) | NCT00315081 | 150-05 | May 2006 | May 2008 | April 17, 2006 | April 17, 2006 |
|
||||
30 | NCT00240409 | Completed | Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
208 | All | 30 Years to 80 Years (Adult, Older Adult) | NCT00240409 | 248.516 | July 2003 | August 2004 | August 2004 | October 18, 2005 | November 4, 2013 |
|
|||
31 | NCT00004300 | Suspended | Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis |
|
|
Interventional |
Phase 2 |
|
NIH / Other |
|
40 | All | 18 Years to 55 Years (Adult) | NCT00004300 | 199/11754 UF-63394 |
October 19, 1999 | October 6, 2010 |
|
|||||||
32 | NCT03353025 | Recruiting | Study on Therapy of Non-invasive Prolactinoma |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
394 | All | 18 Years to 60 Years (Adult) | NCT03353025 | 2016008 | TNAPA | January 1, 2016 | December 31, 2025 | December 31, 2025 | November 24, 2017 | November 24, 2017 |
|
||
33 | NCT00004793 | Completed | Pilot Study of the Effect of Baclofen and Bromocriptine on Luteinizing Hormone Secretion in Pubertal Children |
|
Observational |
|
NIH / Other |
|
4 | All | up to 18 Years (Child, Adult) | NCT00004793 | 199/11923 UMMC-1354 |
June 1995 | February 25, 2000 | June 24, 2005 | |||||||||
34 | NCT00704860 | Completed | Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
27 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT00704860 | REB- 200506 | February 2005 | November 2009 | December 2010 | June 25, 2008 | January 19, 2011 |
|
|||
35 | NCT03714763 | Not yet recruiting | Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA) |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
50 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03714763 | DD2RN-2018 | November 1, 2018 | November 30, 2021 | January 31, 2022 | October 22, 2018 | October 22, 2018 | ||||
36 | NCT00605683 | Completed | MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
679 | All | 30 Years to 80 Years (Adult, Older Adult) | NCT00605683 | 27918 63,901 EudraCT: 2007-002963-28 |
MOTION | November 2007 | January 2012 | March 2012 | January 31, 2008 | October 29, 2013 |
|
||
37 | NCT02696512 | Unknown † | A Study of IBRF Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Severe Disorders of Consciousness |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
30 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT02696512 | IBRF-01-10 | March 2016 | March 2017 | April 2017 | March 2, 2016 | September 2, 2016 |
|
|||
38 | NCT03492580 | Completed | A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease |
|
|
Observational |
|
Industry |
|
|
714582 | All | Child, Adult, Older Adult | NCT03492580 | CR108464 RRA-20250 |
February 22, 2018 | April 6, 2018 | June 25, 2018 | April 10, 2018 | August 27, 2018 |
|
† Study has passed its completion date and status has not been verified in more than two years.